Evidence map›Paper›PMID 28349067›Full record

ArticleBioMed research international2017

A Noninvasive Score Model for Prediction of NASH in Patients with Chronic Hepatitis B and Nonalcoholic Fatty Liver Disease.

Jing Liang, Fang Liu, Fengmei Wang, Tao Han, Li Jing, Zhe Ma, Yingtang Gao

Abstract read
In one paragraph

Article in BioMed research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. [Characteristics, diagnostic and therapeutic strategies for chronic hepatitis B combined with non-alcoholic fatty liver disease].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2020
    Article
  10. [Study of reactive oxygen species and adiponectin for chronic HBV infection combined with nonalcoholic fatty liver diseases].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2020
    Article
  11. [Clinical research advances in chronic hepatitis B complicated by fatty liver disease].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2018
    Article
  12. [Effect of transforming growth factor-β1 on HBV replication and antigen synthesis in HepG2.2.15 cells with steatosis].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jing LiangDepartment of Gastroenterology and Hepatology, Tianjin Third Central Hospital, Tianjin 300170, China; Tianjin Key Laboratory of Artificial Cell, Tianjin 300170, China; Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin 300170, China.
Fang LiuDepartment of Gastroenterology and Hepatology, Tianjin Third Central Hospital, Tianjin 300170, China; Tianjin Key Laboratory of Artificial Cell, Tianjin 300170, China; Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin 300170, China.
Fengmei WangDepartment of Gastroenterology and Hepatology, Tianjin Third Central Hospital, Tianjin 300170, China; Tianjin Key Laboratory of Artificial Cell, Tianjin 300170, China; Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin 300170, China.ORCID 0000-0002-1313-4169
Tao HanDepartment of Gastroenterology and Hepatology, Tianjin Third Central Hospital, Tianjin 300170, China; Tianjin Key Laboratory of Artificial Cell, Tianjin 300170, China; Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin 300170, China.
Li JingTianjin Key Laboratory of Artificial Cell, Tianjin 300170, China; Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin 300170, China; Molecular Biology Laboratory, Tianjin Third Central Hospital, Tianjin 300170, China.
Zhe MaDepartment of Pathology, Tianjin Third Central Hospital, Tianjin 300170, China.
Yingtang GaoTianjin Key Laboratory of Artificial Cell, Tianjin 300170, China; Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin 300170, China; Molecular Biology Laboratory, Tianjin Third Central Hospital, Tianjin 300170, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PrognosisAdultBiomarkersBiopsyBlood GlucoseFemaleHepatitis B, ChronicHepatitis B e AntigensHumansKeratin-18LiverLogistic ModelsMaleMiddle AgedNon-alcoholic Fatty Liver DiseaseBiomarkersBlood GlucoseHepatitis B e AntigensKeratin-18KRT18 protein, human

Identifiers

PMID28349067
PMCPMC5352864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.